| Literature DB >> 28173711 |
Ying Chi1, Zu-Neng Lu1.
Abstract
Objective To examine patency of the cerebral anterior and posterior communicating arteries in patients with ischaemic stroke with or without diabetes mellitus. Methods This retrospective study included patients with acute ischaemic stroke treated between July 2011 and May 2016. Cerebral infarction was evaluated by magnetic resonance imaging. Anterior and posterior communicating-artery patency was determined using magnetic resonance angiography. Vessels were defined as patent or occluded. Results Out of 1 406 patients, incidence of vertebral basilar artery brain infarction and posterior cerebral artery brain infarction were significantly higher in patients with diabetes versus those without diabetes (35.5% versus 22.3% and 11.7% versus 6.8%, respectively). Among patients with posterior cerebral artery brain infarction, anterior and posterior communicating-artery patency rates were higher in patients with diabetes versus those without diabetes (66.7 versus 23.5% and 33.3% versus 5.9% [bilateral], respectively). Among patients with vertebral basilar artery infarction and posterior cerebral artery P1 segment infarction, patency rate of the anterior communicating artery was higher in patients with diabetes versus those without diabetes (55.7% versus 45.9%). Conclusion Among patients with ischaemic stroke, patency rate of the circle of Willis may be higher in patients with diabetes than those without diabetes.Entities:
Keywords: Ischaemic stroke; circle of Willis; anterior communicating artery; diabetes mellitus; posterior communicating artery; risk factors
Mesh:
Year: 2017 PMID: 28173711 PMCID: PMC5536673 DOI: 10.1177/0300060516685205
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Demographic and clinical characteristics of patients with acute ischaemic stroke with or without diabetes mellitus.
| Study group | ||||
|---|---|---|---|---|
| Characteristic | All patients ( | With diabetes ( | Without diabetes ( | Statistical significance |
| Age, years | 61.4 ± 12.1 | 62.2 ± 11.0 | 60.9 ± 12.8 | NS |
| Sex, male | 924 (65.7) | 262 (63.6) | 662 (66.6) | NS |
| Smoker | 594 (42.2) | 162 (39.3) | 432 (43.5) | NS |
| Family stroke history | 20 (1.4) | 8 (1.9) | 12 (1.2) | NS |
| Stroke history | 112 (8.0) | 36 (8.7) | 76 (7.6) | NS |
| Hyperhomocysteinaemia | 392 (27.9) | 100 (24.3) | 292 (29.4) | NS |
| Hyperuricaemia | 182 (12.9) | 52 (12.6) | 130 (13.1) | NS |
| Hypertension | 944 (67.1) | 326 (79.1) | 618 (62.2) | |
| Hyperlipidaemia | 560 (39.8) | 200 (48.5) | 360 (36.2) | |
| Atrial fibrillation | 104 (7.4) | 24 (5.8) | 80 (8.0) | NS |
Data presented as mean ± SD, or n (%) prevalence.
Smoker, currently smoking or smoking cessation for <6 months; family stroke history, first-degree relative with a history of transient ischaemic attack (TIA), ischaemic stroke, or haemorrhagic stroke; stroke history, medical history of TIA, ischaemic stroke, or haemorrhagic stroke; hyperhomocysteinaemia, homocysteine >17 µmol/l; hyperuricemia, uric acid >430 µmol/l; hypertension, blood pressure >140/90 mmHg, or anti-hypertensive medication; hyperlipidaemia, total cholesterol >5.2 mmol/l, or low-density lipoprotein cholesterol >3.1 mmol/l, or triglyceride >1.7 mmol/l.
NS, no statistically significant between group difference (P > 0.05; Student’s t-test, Pearson’s χ2-test, or Mann–Whitney U-test).
Comparison of cerebral infarction sites in 1 406 patients with acute ischaemic stroke with or without diabetes mellitus.
| Study group | |||
|---|---|---|---|
| Cerebral infarction site | With diabetes ( | Without diabetes ( | Statistical significance |
| Anterior circulation brain infarction | 222 (53.9) | 704 (70.8) | |
| VBABI | 142 (35.5) | 222 (22.3) | |
| Posterior cerebral artery brain infarction | 48 (11.7) | 68 (6.8) | |
Data presented as n (%) incidence.
VBABI, vertebral basilar artery infarction and posterior cerebral artery P1 segment infarction.
Statistically significant between-group differences (P < 0.05; Pearson’s χ2-test).
Patency rates of anterior and posterior communicating arteries in 1 406 patients with acute ischaemic stroke with or without diabetes mellitus.
| Study group | |||
|---|---|---|---|
| Patency status | With diabetes ( | Without diabetes ( | Statistical significance |
| Anterior communicating artery | |||
| Patency | 210 (51.0) | 410 (41.2) | |
| Posterior communicating artery | |||
| Bilateral occlusion (0) | 229 (55.6) | 640 (64.4) | |
| Unilateral occlusion (1) | 111 (26.9) | 222 (22.3) | |
| Bilateral patency (2) | 72 (17.5) | 132 (13.3) | |
Data presented as n (%) prevalence.
Statistically significant between-group differences (P < 0.05; Pearson’s χ2-test or Mann–Whitney U-test).
Patency rates of the anterior and posterior communicating arteries according to infarction site in 1 406 patients with acute ischaemic stroke with or without diabetes mellitus.
| Study group | |||
|---|---|---|---|
| Patency status | With diabetes | Without diabetes | Statistical significance |
| Anterior circulation brain infarction | |||
| Anterior communicating artery | |||
| Patency | 96 (43.2) | 292 (41.5) | NS |
| Posterior communicating artery | |||
| Bilateral occlusion (0) | 123 (55.4) | 438 (62.2) | NS |
| Unilateral occlusion (1) | 57 (25.7) | 158 (22.4) | |
| Bilateral patency (2) | 42 (18.9) | 108 (15.3) | |
| VBABI | |||
| Anterior communicating artery | |||
| Patency | 82 (57.7) | 102 (45.9) | |
| Posterior communicating artery | |||
| Bilateral occlusion (0) | 94 (66.2) | 146 (65.8) | NS |
| Unilateral occlusion (1) | 34 (23.9) | 56 (25.2) | |
| Bilateral patency (2) | 14 (9.9) | 20 (9.0) | |
| Posterior cerebral artery brain infarction | |||
| Anterior communicating artery | |||
| Patency | 32 (66.7) | 16 (23.5) | |
| Posterior communicating artery | |||
| Bilateral occlusion (0) | 12 (25.0) | 56 (82.4) | |
| Unilateral occlusion (1) | 20 (41.7) | 8 (11.8) | |
| Bilateral patency (2) | 16 (33.3) | 4 (5.9) | |
Data presented as n (%) prevalence.
VBABI, vertebral basilar artery infarction and posterior cerebral artery P1 segment infarction.
NS, no statistically significant between-group difference (P > 0.05; Pearson’s χ2-test or Mann–Whitney U-test).